Who Paid My Doc
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Cont
Research payments
$3,659,542
Through program year 2025, $3,659,542 in research payments was reported against A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Cont, across 1,379 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $280,136 | 67 |
| 2024 | Research | $748,632 | 230 |
| 2023 | Research | $680,138 | 166 |
| 2022 | Research | $592,363 | 145 |
| 2021 | Research | $520,348 | 256 |
| 2020 | Research | $837,924 | 515 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Humberto Cruz Orlando, FL Named on 88 payments
- Amit Shah Fort Mill, SC Named on 81 payments
- Barry Sigal Winston Salem, NC Named on 65 payments
- Stephen Jones Shelby, NC Named on 45 payments
- Jason Thomason Winston Salem, NC Named on 44 payments
- John Trimble Adairsville, GA Named on 39 payments
- Paul Weinberg Lawrenceville, GA Named on 33 payments
- Sudhir Sehgal Huntsville, TX Named on 28 payments
- Francis Averill Clearwater, FL Named on 28 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.